Researchers repurpose pain meds to kill cancer cells
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy. In a recent study published in Oncogene, the researchers successfully translated DrugPredict results into the laboratory, and showed common pain medications—like aspirin—can kill patient-derived epithelial ovarian cancer cells.
In the new study, DrugPredict suggested non-steroidal anti-inflammatory drugs, also known as NSAIDs, could have applications for epithelial ovarian cancer. The researchers exposed patient-derived epithelial ovarian cancer cells growing in their laboratory to a specific NSAID, indomethacin, and confirmed the DrugPredict finding. Indomethacin killed both drug-resistant and drug-sensitive epithelial ovarian cancer cells. Interestingly, cisplatin-resistant epithelial ovarian cancer cells were most sensitive to indomethacin. When the researchers added chemotherapy drugs to the experiments, the cancer cells died even faster. The findings could represent the first step toward a new therapy regimen for epithelial ovarian cancer.
Epithelial ovarian cancer is the fifth leading cause of cancer deaths in women, killing approximately 14,000 women annually in the United States. Available therapies are only moderately successful, with more than 70 percent of women dying within five years of diagnosis. According to the authors, part of the challenge in developing new ovarian cancer drugs lies in escalating clinical trial costs and lengthy drug development timelines. Programs like DrugPredict could “reposition” FDA-approved medications for new indications—a more efficient strategy.
“Traditional drug discovery process takes an average of 14 years and billions of dollars of investment for a lead anti-cancer drug to make the transition from lab to clinic,” said study first author Anil Belur Nagaraj, PhD, research associate at Case Western Reserve University School of Medicine. “Drug re-positioning significantly shortens the long lag-phase in drug discovery and also reduces the associated cost.”
DrugPredict was developed by co-first author QuanQiu Wang of ThinTek, LLC, and co-senior author Rong Xu, PhD, associate professor of biomedical informatics in the department of population and quantitative health sciences at Case Western Reserve University School of Medicine. The program works by connecting computer-generated drug profiles—including mechanisms of action, clinical efficacy, and side effects— with information about how a molecule may interact with human proteins in specific diseases, such as ovarian cancer.
DrugPredict searches databases of FDA-approved drugs, chemicals, and other naturally occurring compounds. It finds compounds with characteristics related to a disease-fighting mechanism. These include observable characteristics—phenotypes—and genetic factors that may influence drug efficacy. Researchers can collaborate with Xu to input a disease into DrugPredict and receive an output list of drugs—or potential drugs—with molecular features that correlate with strategies to fight the disease.
“For any given disease, DrugPredict simultaneously performs both a target-based, and phenotypic screening of over half a million chemicals, all in just a few minutes,” Xu said.
In the Oncogene study, DrugPredict produced a prioritized list of 6,996 chemicals with potential to treat epithelial ovarian cancer. At the top of the list were 15 drugs already FDA-approved to treat the cancer, helping to validate the DrugPredict approach. Of other FDA-approved medications on the list, NSAIDs ranked significantly higher than other drug classes. The researchers combined the DrugPredict results with anecdotal evidence about NSAIDs and cancer before confirming DrugPredict results in their laboratory experiments.
The program could help identify safe alternatives for diseases—like epithelial ovarian cancer—that desperately require new treatment options. “The primary advantage of drug re-positioning over traditional drug development is that it starts from compounds with well-characterized pharmacology and safety profiles. This significantly reduces the risk of adverse effects and attrition in clinical trials,” Xu said.
“By combining my laboratory’s expertise in ovarian cancer biology and Dr. Xu’s expertise in bioinformatics, we were able to uncover a potentially novel drug approach to treat ovarian cancer,” said co-senior author Analisa DiFeo, PhD, the Norma C. and Albert I. Geller Designated Professor of Ovarian Cancer Research and assistant professor in the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine.
Said Nagaraj, “Currently there are no drugs targeting cancer stem cells being evaluated in ovarian cancer clinical trials. Our results provide a rationale to test NSAIDs like Indomethacin as a novel drug in ovarian cancer clinical trials.”
DiFeo is planning to test indomethacin’s ability to specifically target ovarian cancer stem cells in patient tumors in a phase 1 clinical trial. She will conduct the trial in collaboration with Steven Waggoner, MD, division chief of gynecologic oncology at University Hospitals Seidman Cancer Center and professor of obstetrics and gynecology at Case Western Reserve University School of Medicine.
Learn more: Computer Program Finds New Uses for Old Drugs
The Latest on: Predictive computer program
- New statistical model improves the predictive power of standardized test scoreson November 19, 2019 at 1:14 pm
"Dynamic measurement modeling does not require a specialized computer to run and does not take much longer than standard statistical models used in this area," McNeish said. "Logistically, all the ...
- Patent Application Titled “Health Insurance Cost Prediction Reporting Via Private Transfer Learning” Published Online (USPTO 20190333155)on November 18, 2019 at 3:13 pm
and generating a performance evaluation based on the generated predictive model. “20. A computer program product for generating and reporting a plurality of health insurance cost predictions via ...
- AI, predictive analytics, consortium data at forefront of fraud fight, says SAS on Fraud Weekon November 18, 2019 at 2:19 pm
"SAS solutions deliver a holistic view of fraud risk along with predictive capabilities and AI to help protect against evolving ... Is the person transacting on the other side of that computer or ...
- Why Stock Charts Are a More Valuable Tool Than Everon November 16, 2019 at 7:05 am
In the age of computer algorithms ... The main disagreement about charts is their value as predictive devices. Technicians claim that certain chart patterns increase the odds of a specific ...
- Predictive text, typos and resume blooperson November 15, 2019 at 8:02 am
The “predictive” word feature on the phone sometimes gets me ... Education: Curses in liberal arts, curses in computer science, curses in accounting.” • “Instrumental in ruining entire operation for a ...
- Business Analytics Market Research Reports 2018 | Global Industry Size, In-Depth Qualitative Insights, Explosive Growth 2023on November 15, 2019 at 3:32 am
Nov 15, 2019 (AmericaNewsHour) -- Global Business Analytics Market Research Report, By Software (Predictive Analytics ... applied statistics, computer science, and signal processing for using data to ...
- How predictive mapping can help railways cut noise pollutionon November 14, 2019 at 2:52 pm
Having debuted in 1986, the software solution was developed by an interdisciplinary team consisting of engineers, geographers, physicists and computer science specialists, he says. “The EBA has now ...
- While Predictive/Preventive Maintenance Is Still King, Maintenance Personnel Are Reluctant to Use Internet-based Maintenanceon November 14, 2019 at 2:35 pm
as most machines now interact with internet-based software to provide and track real-time data. We asked respondents which best represents the current level of predictive maintenance at their facility ...
- Public Health Professor highlights how digital technologies can improve care in underserved areason November 14, 2019 at 9:07 am
Agarwal’s research advances maternal and child health through the innovative use of digital tools for clinical decision-support and the use of predictive analytics-based algorithms to improve quality ...
- Lights, Camera, and … Text! Novel Video Editing Tool for User-Friendly, Predictive Text-to-Video Productionon November 14, 2019 at 12:17 am
A global team of computer scientists, from Tsinghua and Beihang Universities in China ... sometimes even faster than professionals utilizing frame-based editing software. At SIGGRAPH Asia, the team ...
via Google News and Bing News